Michelle J. West
Brighton, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Repression of CADM1 transcription by HPV type 18 is mediated by three-dimensional rearrangement of promoter-enhancer interactions.
Journal: PLoS pathogens
Published: August 15, 2024
A Shared Receptor Suggests a Common Ancestry between an Insecticidal Bacillus thuringiensis Cry Protein and an Anti-Cancer Parasporin.
Journal: Biomolecules
Published: June 05, 2024
Regulation of B cell receptor signalling by Epstein-Barr virus nuclear antigens.
Journal: The Biochemical journal
Published: August 06, 2022
Dissecting the impact of bromodomain inhibitors on the Interferon Regulatory Factor 4-MYC oncogenic axis in multiple myeloma.
Journal: Hematological oncology
Published: November 22, 2021
Differential proteolytic activation of the Bacillus thuringiensis Cry41Aa parasporin modulates its anticancer effect.
Journal: The Biochemical journal
Published: October 01, 2019
The role of membrane-bound metal ions in toxicity of a human cancer cell-active pore-forming toxin Cry41Aa from Bacillus thuringiensis.
Journal: Toxicon : official journal of the International Society on Toxinology
Published: March 04, 2019
Increased association between Epstein-Barr virus EBNA2 from type 2 strains and the transcriptional repressor BS69 restricts EBNA2 activity.
Journal: PLoS pathogens
Published: November 02, 2018
Enhancer Control of MicroRNA miR-155 Expression in Epstein-Barr Virus-Infected B Cells.
Journal: Journal of virology
Published: April 30, 2018
Disruption of CTCF-YY1-dependent looping of the human papillomavirus genome activates differentiation-induced viral oncogene transcription.
Journal: PLoS biology
Published: February 20, 2018
Pumilio directs deadenylation-associated translational repression of the cyclin-dependent kinase 1 activator RGC-32.
Journal: Nucleic acids research
Published: January 03, 2018
Last Updated: 09/26/2026